TNF and neoplasm: Herein, we noticed that anti-PD-1 therapeutic effect was dramatically enhanced in TNFR1-deficient mice, indicating that TNFR1-dependent TNF signalling in the tumor microenvironment also critically contributes to anti-PD-1 therapy resistance.